On May 25, 2023, Pharosgen Co., Ltd. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,440 KRW | -2.75% | -.--% | -11.32% |
1st Jan change | Capi. | |
---|---|---|
-11.32% | 13Cr | |
+37.78% | 71TCr | |
+32.82% | 58TCr | |
-3.51% | 36TCr | |
+19.94% | 33TCr | |
+5.14% | 29TCr | |
+16.64% | 24TCr | |
-4.13% | 21TCr | |
+10.63% | 21TCr | |
+9.32% | 17TCr |
- Stock Market
- Equities
- A214390 Stock
- News Kyongbo Pharmaceutical Co., Ltd
- Pharosgen Co., Ltd. announced that it has received KRW 1.999997692 billion in funding from Kyongbo Pharmaceutical Co., Ltd